EyePoint (EYPT) FCF Margin (2010 - 2026)

EyePoint (EYPT) reported FCF Margin of 11587.36% for Q1 2026, down 1136994.0% on a YoY basis from N/an in Q1 2025, and down 5.28% sequentially from 11006.61% in Q4 2025.

EyePoint (EYPT) FCF Margin (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 17 years of FCF Margin data on file, last reported at 11587.36% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 1136994.0% year-over-year to 11587.36%; the trailing twelve-month figure through Mar 2026 stood at 3557.11% (down 328636.0% YoY), and the FY2025 full-year result was 775.84%, down 47478.0% from the prior year.
  • FCF Margin retreated to 11587.36% in Q1 2026, from 11006.61% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 631.6% in Q2 2023 to a low of 11587.36% in Q1 2026.
  • A 5-year average of 1872.99% and a median of 218.5% in 2022 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin surged 79884 bps in 2023 and plunged 1136994 bps in 2026, its largest moves.
  • Tracing EYPT's FCF Margin over 5 years: stood at 125.06% in 2022, then plunged by 32 bps to 164.73% in 2023, then sank by 96 bps to 323.43% in 2024, then sank by 3303 bps to 11006.61% in 2025, then retreated by 5 bps to 11587.36% in 2026.
  • Business Quant data shows EYPT's FCF Margin at 11587.36% in Q1 2026, 11006.61% in Q4 2025, and 6146.79% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 -11,587.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,587.36%
Dec 31, 2025 -11,006.61%
Sep 30, 2025 -6,146.79%
Jun 30, 2025 -1,173.95%
Mar 31, 2025 -217.41%
Dec 31, 2024 -323.43%
Sep 30, 2024 -391.77%
Jun 30, 2024 -209.59%
Mar 31, 2024 -271.36%
Dec 31, 2023 -164.73%
Sep 30, 2023 -100.01%
Jun 30, 2023 631.60%
Mar 31, 2023 -225.42%
Dec 31, 2022 -125.06%
Sep 30, 2022 -143.17%
Jun 30, 2022 -167.24%
Mar 31, 2022 -218.50%
Dec 31, 2021 -144.39%
Sep 30, 2021 -87.40%
Jun 30, 2021 -117.25%